Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home > England & Wales Companies > APTUIT (OXFORD) LIMITED
Company Information for

APTUIT (OXFORD) LIMITED

111 INNOVATION DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, OX14 4RZ,
Company Registration Number
07710692
Private Limited Company
Active

Company Overview

About Aptuit (oxford) Ltd
APTUIT (OXFORD) LIMITED was founded on 2011-07-19 and has its registered office in Abingdon. The organisation's status is listed as "Active". Aptuit (oxford) Limited is a Private Limited Company registered in with Companies House and the accounts submission requirement is categorised as FULL
  • Annual turnover is £6.5 million or more
  • The balance sheet total is £ 3.26 million or more
  • Employs 50 or more employees
  • May be publically listed
  • May be a member of a group of companies meeting any of the above criteria
Key Data
Company Name
APTUIT (OXFORD) LIMITED
 
Legal Registered Office
111 INNOVATION DRIVE
MILTON PARK
ABINGDON
OXFORDSHIRE
OX14 4RZ
Other companies in OX14
 
Filing Information
Company Number 07710692
Company ID Number 07710692
Date formed 2011-07-19
Country 
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus Active
Lastest accounts 31/12/2022
Account next due 31/12/2024
Latest return 19/07/2015
Return next due 16/08/2016
Type of accounts FULL
VAT Number /Sales tax ID GB125040463  
Last Datalog update: 2024-10-05 20:24:32
Primary Source:Companies House
There are multiple companies registered at this address, the registered address may be the accountant's offices for APTUIT (OXFORD) LIMITED
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of APTUIT (OXFORD) LIMITED

Current Directors
Officer Role Date Appointed
CHRISTIAN DARGEL
Company Secretary 2017-08-11
PETRA DIETERICH
Director 2017-08-11
MARIO EUGENIO COSIMINO POLYWKA
Director 2017-08-11
RALPH ENNO SPILLNER
Director 2017-08-11
Previous Officers
Officer Role Date Appointed Date Resigned
JONATHAN HOWARD GOLDMAN
Director 2014-01-06 2017-09-30
JOHN FIKRE
Company Secretary 2011-07-19 2017-08-11
KURT ERIC DINKELACKER
Director 2013-03-13 2017-08-11
JOHN FIKRE
Director 2011-07-19 2017-08-11
STUART EVAN NEEDLEMAN
Director 2012-03-16 2014-02-19
KENNETH ALBERT ROCHE
Director 2012-03-16 2012-12-10
TIMOTHY CYRIL TYSON
Director 2011-07-19 2012-03-15
THIERRY GEORGES AMAT
Director 2011-07-19 2012-02-29

Related Directorships

Officer Related Company Role Date Appointed Role StatusIncorporation dateCompany Status
MARIO EUGENIO COSIMINO POLYWKA EXSCIENTIA AI LIMITED Director 2017-09-27 CURRENT 2012-07-20 Active
MARIO EUGENIO COSIMINO POLYWKA APTUIT (POTTERS BAR) LIMITED Director 2017-08-11 CURRENT 2007-06-27 Active
MARIO EUGENIO COSIMINO POLYWKA CYPROTEX DISCOVERY LIMITED Director 2017-03-15 CURRENT 2001-03-21 Active
MARIO EUGENIO COSIMINO POLYWKA CYPROTEX LIMITED Director 2017-03-15 CURRENT 2001-10-25 Active
MARIO EUGENIO COSIMINO POLYWKA PANION LIMITED Director 2015-12-01 CURRENT 2013-02-21 Active
MARIO EUGENIO COSIMINO POLYWKA EUPROTEC LIMITED Director 2014-05-27 CURRENT 2008-07-02 Active - Proposal to Strike off
MARIO EUGENIO COSIMINO POLYWKA EVOTEC (UK) LIMITED Director 2005-05-20 CURRENT 1991-12-19 Active
MARIO EUGENIO COSIMINO POLYWKA PHARMINOX LIMITED Director 2002-10-16 CURRENT 2001-12-28 Active - Proposal to Strike off
RALPH ENNO SPILLNER APTUIT (POTTERS BAR) LIMITED Director 2017-08-11 CURRENT 2007-06-27 Active
RALPH ENNO SPILLNER CYPROTEX DISCOVERY LIMITED Director 2017-03-15 CURRENT 2001-03-21 Active
RALPH ENNO SPILLNER CYPROTEX LIMITED Director 2017-03-15 CURRENT 2001-10-25 Active

More director information

Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2024-08-30Termination of appointment of Mary Abdul on 2024-08-30
2024-08-30Appointment of Dr Krisztina Petreczky as company secretary on 2024-08-30
2024-07-19CONFIRMATION STATEMENT MADE ON 19/07/24, WITH UPDATES
2024-03-0806/03/24 STATEMENT OF CAPITAL GBP 14249
2023-11-29FULL ACCOUNTS MADE UP TO 31/12/22
2023-07-27CONFIRMATION STATEMENT MADE ON 19/07/23, WITH NO UPDATES
2023-06-02APPOINTMENT TERMINATED, DIRECTOR CIRIACO MARASCHIELLO
2023-03-30APPOINTMENT TERMINATED, DIRECTOR RALPH ENNO SPILLNER
2023-03-30DIRECTOR APPOINTED CRAIG JOHNSTONE
2022-09-05DIRECTOR APPOINTED DR ADAM STOTEN
2022-09-05AP01DIRECTOR APPOINTED DR ADAM STOTEN
2022-09-02APPOINTMENT TERMINATED, DIRECTOR CHRISTOPHE MULLER
2022-09-02TM01APPOINTMENT TERMINATED, DIRECTOR CHRISTOPHE MULLER
2022-08-30FULL ACCOUNTS MADE UP TO 31/12/21
2022-08-30AAFULL ACCOUNTS MADE UP TO 31/12/21
2022-07-19CS01CONFIRMATION STATEMENT MADE ON 19/07/22, WITH NO UPDATES
2021-08-12AAFULL ACCOUNTS MADE UP TO 31/12/20
2021-07-23CS01CONFIRMATION STATEMENT MADE ON 19/07/21, WITH NO UPDATES
2021-04-13AP03Appointment of Dr Christian Dargel as company secretary on 2021-04-13
2021-04-13TM02Termination of appointment of Ranjeet Singh Sagoo on 2021-04-13
2020-10-19AAFULL ACCOUNTS MADE UP TO 31/12/19
2020-07-20CS01CONFIRMATION STATEMENT MADE ON 19/07/20, WITH NO UPDATES
2019-10-04AAFULL ACCOUNTS MADE UP TO 31/12/18
2019-09-06PSC05Change of details for Evotec Ag as a person with significant control on 2019-03-29
2019-08-05AP03Appointment of Mr Ranjeet Singh Sagoo as company secretary on 2019-08-01
2019-08-05AP01DIRECTOR APPOINTED MR CIRIACO MARASCHIELLO
2019-08-05TM02Termination of appointment of Christian Dargel on 2019-07-31
2019-08-05TM01APPOINTMENT TERMINATED, DIRECTOR PETRA DIETERICH
2019-07-29CS01CONFIRMATION STATEMENT MADE ON 19/07/19, WITH NO UPDATES
2019-02-11AP01DIRECTOR APPOINTED DR CHRISTOPHE MULLER
2019-02-11AP01DIRECTOR APPOINTED DR CHRISTOPHE MULLER
2019-02-11TM01APPOINTMENT TERMINATED, DIRECTOR MARIO EUGENIO COSIMINO POLYWKA
2018-08-01CS01CONFIRMATION STATEMENT MADE ON 19/07/18, WITH NO UPDATES
2018-07-25PSC02Notification of Evotec Ag as a person with significant control on 2017-08-11
2018-07-25PSC09Withdrawal of a person with significant control statement on 2018-07-25
2018-07-23AAFULL ACCOUNTS MADE UP TO 31/12/17
2017-10-09TM01APPOINTMENT TERMINATED, DIRECTOR JONATHAN HOWARD GOLDMAN
2017-09-25MR04 STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 077106920008
2017-08-22AP01DIRECTOR APPOINTED DR PETRA DIETERICH
2017-08-21AP03Appointment of Dr Christian Dargel as company secretary on 2017-08-11
2017-08-21AP01DIRECTOR APPOINTED MR RALPH ENNO SPILLNER
2017-08-21AP01DIRECTOR APPOINTED DR MARIO EUGENIO COSIMINO POLYWKA
2017-08-15TM01APPOINTMENT TERMINATED, DIRECTOR KURT DINKELACKER
2017-08-15TM01APPOINTMENT TERMINATED, DIRECTOR JOHN FIKRE
2017-08-15TM02Termination of appointment of John Fikre on 2017-08-11
2017-07-26CS01CONFIRMATION STATEMENT MADE ON 19/07/17, WITH NO UPDATES
2017-04-11AAFULL ACCOUNTS MADE UP TO 31/12/16
2016-08-16LATEST SOC16/08/16 STATEMENT OF CAPITAL;GBP 14247
2016-08-16CS01CONFIRMATION STATEMENT MADE ON 19/07/16, WITH UPDATES
2016-06-22MR01REGISTRATION OF A CHARGE / CHARGE CODE 077106920008
2016-04-22AAFULL ACCOUNTS MADE UP TO 31/12/15
2015-09-17AAFULL ACCOUNTS MADE UP TO 31/12/14
2015-09-03LATEST SOC03/09/15 STATEMENT OF CAPITAL;GBP 14247
2015-09-03SH0131/07/15 STATEMENT OF CAPITAL GBP 14247.00
2015-07-21AR0119/07/15 ANNUAL RETURN FULL LIST
2015-07-15AA01Previous accounting period shortened from 30/09/15 TO 31/12/14
2015-06-08AAFULL ACCOUNTS MADE UP TO 30/09/14
2014-08-05LATEST SOC05/08/14 STATEMENT OF CAPITAL;GBP 1
2014-08-05AR0119/07/14 FULL LIST
2014-07-07AAFULL ACCOUNTS MADE UP TO 30/09/13
2014-02-25TM01APPOINTMENT TERMINATED, DIRECTOR STUART NEEDLEMAN
2014-02-25AUDAUDITOR'S RESIGNATION
2014-01-30AP01DIRECTOR APPOINTED MR JONATHAN HOWARD GOLDMAN
2013-09-10AAFULL ACCOUNTS MADE UP TO 30/09/12
2013-08-09AR0119/07/13 FULL LIST
2013-03-20AP01DIRECTOR APPOINTED KURT ERIC DINKELACKER
2013-01-28AD01REGISTERED OFFICE CHANGED ON 28/01/2013 FROM UNIT 111 MILTON PARK OXFORD OXFORDSHIRE OX14 4RZ UNITED KINGDOM
2012-12-12TM01APPOINTMENT TERMINATED, DIRECTOR KENNETH ROCHE
2012-08-07AR0119/07/12 FULL LIST
2012-04-11AP01DIRECTOR APPOINTED DR STUART EVAN NEEDLEMAN
2012-04-11AP01DIRECTOR APPOINTED KENNETH ALBERT ROCHE
2012-04-10TM01APPOINTMENT TERMINATED, DIRECTOR TIMOTHY TYSON
2012-04-10TM01APPOINTMENT TERMINATED, DIRECTOR THIERRY AMAT
2012-03-08MG02DECLARATION OF SATISFACTION IN FULL OR IN PART OF A MORTGAGE OR CHARGE /FULL /CHARGE NO 1
2012-03-08MG02DECLARATION OF SATISFACTION IN FULL OR IN PART OF A MORTGAGE OR CHARGE /FULL /CHARGE NO 7
2012-02-23AA01CURREXT FROM 31/07/2012 TO 30/09/2012
2012-01-11MG06PARTICULARS OF A CHARGE SUBJECT TO WHICH A PROPERTY HAS BEEN ACQUIRED / CHARGE NO: 7
2012-01-06MG01PARTICULARS OF A MORTGAGE OR CHARGE / CHARGE NO: 5
2012-01-06MG01PARTICULARS OF A MORTGAGE OR CHARGE / CHARGE NO: 4
2012-01-06MG01PARTICULARS OF A MORTGAGE OR CHARGE / CHARGE NO: 3
2012-01-06MG01PARTICULARS OF A MORTGAGE OR CHARGE / CHARGE NO: 2
2012-01-06MG01PARTICULARS OF A MORTGAGE OR CHARGE / CHARGE NO: 6
2011-09-09MG01PARTICULARS OF A MORTGAGE OR CHARGE / CHARGE NO: 1
2011-08-24RES01ADOPT ARTICLES 27/07/2011
2011-07-19NEWINCCERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION
Industry Information
SIC/NAIC Codes
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
212 - Manufacture of pharmaceutical preparations
21200 - Manufacture of pharmaceutical preparations




Licences & Regulatory approval
We could not find any licences issued to APTUIT (OXFORD) LIMITED or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Risks
Legal Notices
No legal notices or events such as winding-up orders or proposals to strike-off have been issued
Fines / Sanctions
No fines or sanctions have been issued against APTUIT (OXFORD) LIMITED
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 8
Mortgages/Charges outstanding 5
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 3
Details of Mortgagee Charges
Charge Type Date of Charge Charge Status Mortgagee
2016-06-22 Satisfied ARCHOVER LIMITED
RENT SECURITY DEPOSIT DEED 2012-01-06 Outstanding MEPC MILTON PARK NO.1 LIMITED AND MEPC MILTON PARK NO.2 LIMITED
RENT SECURITY DEPOSIT DEED 2012-01-06 Outstanding MEPC MILTON PARK NO.1 LIMITED AND MEPC MILTON PARK NO.2 LIMITED
RENT SECURITY DEPOSIT DEED 2012-01-06 Outstanding MEPC MILTON PARK NO.1 LIMITED AND MEPC MILTON PARK NO.2 LIMITED
RENT SECURITY DEPOSIT DEED 2012-01-06 Outstanding MEPC MILTON PARK NO.1 LIMITED AND MEPC MILTON PARK NO.2 LIMITED
RENT SECURITY DEPOSIT DEED 2012-01-06 Outstanding MEPC MILTON PARK NO.1 LIMITED AND MEPC MILTON PARK NO.2 LIMITED
DEBENTURE 2011-09-02 Satisfied GENERAL ELECTRIC CAPITAL CORPORATION
AMENDED AND RESTATED DEBENTURE 2007-11-30 Satisfied GENERAL ELECTRIC CAPITAL CORPORATION
Filed Financial Reports
Annual Accounts
2014-09-30
Annual Accounts
2013-09-30
Annual Accounts
2012-09-30

These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on APTUIT (OXFORD) LIMITED

Intangible Assets
Patents
We have not found any records of APTUIT (OXFORD) LIMITED registering or being granted any patents
Domain Names
We do not have the domain name information for APTUIT (OXFORD) LIMITED
Trademarks
We have not found any records of APTUIT (OXFORD) LIMITED registering or being granted any trademarks
Income
Government Income
We have not found government income sources for APTUIT (OXFORD) LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (21200 - Manufacture of pharmaceutical preparations) as APTUIT (OXFORD) LIMITED are:

Outgoings
Business Rates/Property Tax
No properties were found where APTUIT (OXFORD) LIMITED is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Import/Export of Goods
Goods imported/exported by APTUIT (OXFORD) LIMITED
OriginDestinationDateImport CodeImported Goods classification description
2015-07-0129061900Cyclanic, cyclenic or cycloterpenic alcohols and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. menthol, cyclohexanol, methylcyclohexanols, dimethylcyclohexanols, sterols and inositols)
2015-07-0129333999Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami
2015-07-0129420000Separate chemically defined organic compounds, n.e.s.
2015-07-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-06-0129339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2015-06-0129419000Antibiotics (excl. penicillins and their derivatives with a penicillanic acid structure, salts thereof, streptomycins, tetracyclines, chloramphenicol and erythromycin, their derivatives and salts thereof)
2015-06-0129420000Separate chemically defined organic compounds, n.e.s.
2015-04-0129214900Aromatic monoamines and derivatives; salts thereof (excl. aniline, toluidines, diphenylamine, 1-naphthylamine "alpha-naphthylamine", 2-naphthylamine "beta-naphthylamine" and their derivatives, and salts thereof, and amfetamine "INN", benzfetamine "INN", dexamfetamine "INN", etilamfetamine "INN", fencamfamine "INN", lefetamine "INN", levamfetamine "INN", mefenorex "INN" and phentermine "INN", and salts thereof)
2015-03-0129419000Antibiotics (excl. penicillins and their derivatives with a penicillanic acid structure, salts thereof, streptomycins, tetracyclines, chloramphenicol and erythromycin, their derivatives and salts thereof)
2015-01-0129419000Antibiotics (excl. penicillins and their derivatives with a penicillanic acid structure, salts thereof, streptomycins, tetracyclines, chloramphenicol and erythromycin, their derivatives and salts thereof)
2014-12-0129329900Heterocyclic compounds with oxygen hetero-atom[s] only (excl. compounds containing unfused furan ring, whether or not hydrogenated, in the structure, and lactones, isosafrole, 1-[1,3-benzodioxol-5-yl]propan-2-one, piperonal, safrole, tetrahydrocannabinols "all isomers", and inorganic or organic compounds of mercury)
2014-12-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2014-12-0130039000Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. antibiotics containing hormones or steroids used as hormones, but not containing antibiotics, alkaloids or derivatives thereof, hormones or antibiotics or goods of heading 3002, 3005 or 3006)
2014-11-0129329900Heterocyclic compounds with oxygen hetero-atom[s] only (excl. compounds containing unfused furan ring, whether or not hydrogenated, in the structure, and lactones, isosafrole, 1-[1,3-benzodioxol-5-yl]propan-2-one, piperonal, safrole, tetrahydrocannabinols "all isomers", and inorganic or organic compounds of mercury)
2014-10-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-08-0129039990Halogenated derivatives of aromatic hydrocarbons (excl. chlorobenzene, o-dichlorobenzene, p-dichlorobenzene, hexachlorobenzene [ISO], DDT [ISO] "clofenotane [INN], 1,1,1-trichloro-2,2-bis[p-chlorophenyl]ethane" and 2,3,4,5,6-Pentabromoethylbenzene)
2014-08-0129420000Separate chemically defined organic compounds, n.e.s.
2014-08-0184198998Machinery, plant or laboratory equipment, whether or not electrically heated, for the treatment of materials by a process involving a change of temperature, n.e.s.
2014-06-0129333999Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami
2014-04-0129319090Separate chemically defined organo-inorganic compounds (excl. organo-sulphur compounds, tributyltin compounds, tetramethyl lead, tetraethyl lead, dimethyl methylphosphonate, methylphosphonoyl difluoride "methylphosphonic difluoride", methylphosphonoyl dichloride "methylphosphonic dichloride" and those of mercury and (5-Ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl methyl methylphosphonate; bis[(5-ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl] methylphosphonate; 2,4,6-tripro
2014-04-0129342080Heterocyclic compounds containing in the structure a benzothiazole ring-system, whether or not hydrogenated, but not further fused (excl. di"benzothiazol-2-yl"disulphide; benzothiazole-2-thiol "mercaptobenzothiazole" and its salts, and inorganic or organic compounds of mercury)
2014-04-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2014-04-0184198998Machinery, plant or laboratory equipment, whether or not electrically heated, for the treatment of materials by a process involving a change of temperature, n.e.s.
2014-03-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2014-02-0129
2014-02-0129039990Halogenated derivatives of aromatic hydrocarbons (excl. chlorobenzene, o-dichlorobenzene, p-dichlorobenzene, hexachlorobenzene [ISO], DDT [ISO] "clofenotane [INN], 1,1,1-trichloro-2,2-bis[p-chlorophenyl]ethane" and 2,3,4,5,6-Pentabromoethylbenzene)
2014-02-0129089900Halogenated, sulphonated, nitrated or nitrosated derivatives of phenols or phenol-alcohols (excl. derivatives containing only halogen substitutes and their salts, dinoseb [ISO] and its salts, and 4,6-Dinitro-o-cresol [DNOC [ISO]] and its salts)
2014-02-0129333999Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami
2014-02-0129337900Lactams (excl. 6-hexanelactam "epsilon-caprolactam", clobazam "INN", methyprylon "INN", and inorganic or organic compounds of mercury)
2014-02-0130049000Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins
2014-01-0129211999Acyclic monoamines and their derivatives; salts thereof (excl. methylamine, dimethylamine, trimethylamine, diethylamine, and their salts, 1,1,3,3-tetramethylbutylamine, 2-(N,N-Diethylamino)ethyl chloride hydrochloride, 2-(N,N-diisopropylamino)ethyl chloride hydrochloride and 2-(N,N-dimethylamino)ethyl chloride hydrochloride)
2013-12-0129
2013-12-0129039990Halogenated derivatives of aromatic hydrocarbons (excl. chlorobenzene, o-dichlorobenzene, p-dichlorobenzene, hexachlorobenzene [ISO], DDT [ISO] "clofenotane [INN], 1,1,1-trichloro-2,2-bis[p-chlorophenyl]ethane" and 2,3,4,5,6-Pentabromoethylbenzene)
2013-12-0129333999Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami
2013-12-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2013-12-0139072099Polyethers in primary forms (excl. polyether alcohols, polyacetals and copolymer of 1-chloro-2,3-epoxypropane with ethylene oxide)
2013-12-0184193900Dryers (excl. dryers for agricultural products, for wood, paper pulp, paper or paperboard, for yarns, fabrics and other textile products, dryers for bottles or other containers, hairdryers, hand dryers and domestic appliances)
2013-11-0129420000Separate chemically defined organic compounds, n.e.s.
2013-11-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-11-0170200080Articles of glass, n.e.s.
2013-10-0129093090Aromatic ethers and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. diphenyl ether and brominated derivatives)
2013-10-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2013-10-0134042000Poly"oxyethylene" [polyethylene glycol] waxes
2013-10-0139072099Polyethers in primary forms (excl. polyether alcohols, polyacetals and copolymer of 1-chloro-2,3-epoxypropane with ethylene oxide)
2013-09-0129172000Cyclanic, cyclenic or cycloterpenic polycarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives
2013-09-0129309099Organo-sulphur compounds (excl. thiocarbamates and dithiocarbamates, thiuram mono-, di- or tetrasulphides, methionine, captafol [ISO], methamidophos [ISO], cysteine or cystine and their derivatives, thiodiglycol [INN] [2,2-thiodiethanol], DL-2-hydroxy-4-"methylthio"butyric acid, 2,2'-thiodiethyl bis[3-"3,5-di-tert-butyl-4-hydroxyphenyl"propionate], a mixture of isomers consisting of 4-methyl-2,6-bis"methylthio"-m-phenylenediamine and 2-methyl-4,6-bis"methylthio"-m-phenylenediamine and 2-(N,N-Die
2013-09-0129337900Lactams (excl. 6-hexanelactam "epsilon-caprolactam", clobazam "INN", methyprylon "INN", and inorganic or organic compounds of mercury)
2013-09-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2013-09-0184713000Data-processing machines, automatic, portable, weighing <= 10 kg, consisting of at least a central processing unit, a keyboard and a display (excl. peripheral units)
2013-08-0129
2013-08-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2013-07-0129182100Salicylic acid and its salts (excl. inorganic or organic compounds of mercury)
2013-07-0184186900Refrigerating or freezing equipment (excl. refrigerating and freezing furniture)
2013-06-0129309099Organo-sulphur compounds (excl. thiocarbamates and dithiocarbamates, thiuram mono-, di- or tetrasulphides, methionine, captafol [ISO], methamidophos [ISO], cysteine or cystine and their derivatives, thiodiglycol [INN] [2,2-thiodiethanol], DL-2-hydroxy-4-"methylthio"butyric acid, 2,2'-thiodiethyl bis[3-"3,5-di-tert-butyl-4-hydroxyphenyl"propionate], a mixture of isomers consisting of 4-methyl-2,6-bis"methylthio"-m-phenylenediamine and 2-methyl-4,6-bis"methylthio"-m-phenylenediamine and 2-(N,N-Die
2013-06-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2013-05-0129124900Aldehyde-alcohols, aldehyde-ethers, aldehyde-phenols and aldehydes with other oxygen function (excl. ethylvanillin "3-ethoxy-4-hydroxybenzaldehyde" and vanillin "4-hydroxy-3-methoxybenzaldehyde")
2013-05-0129309099Organo-sulphur compounds (excl. thiocarbamates and dithiocarbamates, thiuram mono-, di- or tetrasulphides, methionine, captafol [ISO], methamidophos [ISO], cysteine or cystine and their derivatives, thiodiglycol [INN] [2,2-thiodiethanol], DL-2-hydroxy-4-"methylthio"butyric acid, 2,2'-thiodiethyl bis[3-"3,5-di-tert-butyl-4-hydroxyphenyl"propionate], a mixture of isomers consisting of 4-methyl-2,6-bis"methylthio"-m-phenylenediamine and 2-methyl-4,6-bis"methylthio"-m-phenylenediamine and 2-(N,N-Die
2013-05-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2013-05-0129420000Separate chemically defined organic compounds, n.e.s.
2013-05-0134021300Non-ionic organic surface-active agents, whether or not put up for retail sale (excl. soap)
2013-05-0182057000Vices, clamps and the like (excl. accessories for and parts of machine tools)
2013-02-0129349960Chlorprothixene (INN); thenalidine (INN) and its tartrates and maleates; furazolidone (INN); 7-aminocephalosporanic acid; salts and esters of (6R,7R)-3-acetoxymethyl-7-[(R)-2-formyloxy-2-phenylacetamido]-8- oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 1-[2-(1,3-Dioxan-2-yl)ethyl]-2-methylpyridinium bromide
2013-02-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2013-02-0129420000Separate chemically defined organic compounds, n.e.s.
2013-02-0130049000Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins
2013-01-0129
2013-01-0129093090Aromatic ethers and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. diphenyl ether and brominated derivatives)
2013-01-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2012-12-0129093090Aromatic ethers and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. diphenyl ether and brominated derivatives)
2012-12-0170171000Laboratory, hygienic or pharmaceutical glassware, whether or not graduated or calibrated, of fused quartz or other fused silica (excl. containers for the conveyance or packing of goods, measuring, checking or medical instruments and apparatus of chapter 90)
2012-11-0129093090Aromatic ethers and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. diphenyl ether and brominated derivatives)
2012-11-0170171000Laboratory, hygienic or pharmaceutical glassware, whether or not graduated or calibrated, of fused quartz or other fused silica (excl. containers for the conveyance or packing of goods, measuring, checking or medical instruments and apparatus of chapter 90)
2012-09-0129124900Aldehyde-alcohols, aldehyde-ethers, aldehyde-phenols and aldehydes with other oxygen function (excl. ethylvanillin "3-ethoxy-4-hydroxybenzaldehyde" and vanillin "4-hydroxy-3-methoxybenzaldehyde")
2012-02-0130042000Medicaments containing antibiotics, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing penicillins or derivatives thereof with a penicillanic structure, or streptomycines or derivatives thereof)

For goods imported into the United Kingdom, only imports originating from outside the EU are shown

Government Grants / Awards
Technology Strategy Board Awards
The Technology Strategy Board has not awarded APTUIT (OXFORD) LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR
European Union CORDIS Awards
The European Union has not awarded APTUIT (OXFORD) LIMITED any grants or awards.
Ownership
    We could not find any group structure information
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.